Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer-Reference-Cited by-同舟云学术

Variable modulation by cytokines and thiazolidinediones of the prototype Th1 chemokine CXCL10 in anaplastic thyroid cancer

Published:2012-08 Issue:2 Volume:59 Page:218-222
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Antonelli Alessandro,Ferrari Silvia Martina,Fallahi Poupak,Piaggi Simona,Di Domenicantonio Andrea,Galleri David,Santarpia Libero,Basolo Fulvio,Ferrannini Ele,Miccoli Paolo

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference15 articles.

1. Role of chemokines in tumor growth;Raman;Can Lett,2007

2. Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer;De Falco;Can Res,2007

3. The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells;Melillo;J Clin Invest,2005

4. RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response;Puxeddu;Endocr Relat Can,2005

5. High basal levels of functional toll-like receptor 3 (TLR3) and noncanonical Wnt5a are expressed in papillary thyroid cancer and are coordinately decreased by phenylmethimazole together with cell proliferation and migration;McCall;Endocrinology,2007

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing Immunity to Treat Advanced Thyroid Cancer;Vaccines;2023-12-30

2. Neutrophil extracellular traps and neutrophil-related mediators in human thyroid cancer;Frontiers in Immunology;2023-08-29

3. ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma;Frontiers in Oncology;2022-01-31

4. Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer;Expert Opinion on Investigational Drugs;2021-09-02

5. Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy;Frontiers in Endocrinology;2021-04-16